Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Sales | 1,291 | 7,468 | 6,140 | 8,130 | 8,669 |
| Cost of Goods | 60 | 212 | 246 | 246 | 430 |
| Gross Profit | 1,231 | 7,256 | 5,894 | 7,884 | 8,239 |
| Operating Expenses | -4,364 | 38,282 | 41,888 | 48,027 | 40,152 |
| Operating Income | 5,655 | -30,814 | -35,748 | -39,897 | -31,483 |
| Interest Expense | 2,955 | 3,994 | 3,893 | 2,841 | 2,720 |
| Other Income | -11,204 | -1,367 | 509 | -799 | -706 |
| Pre-tax Income | -8,504 | -36,175 | -39,132 | -43,537 | -34,909 |
| Net Income Continuous | -8,504 | -36,175 | -39,132 | -43,537 | -34,909 |
| Net Income | $-8,504 | $-36,175 | $-39,132 | $-43,537 | $-34,909 |
| EPS Basic Total Ops | -1,559.69 | -6,838.63 | -7,438.51 | -6,598.68 | -7,438.51 |
| EPS Basic Continuous Ops | -1,606.35 | -6,852.55 | -7,416.55 | -6,476.68 | -7,451.86 |
| EPS Diluted Total Ops | -1,559.69 | -6,838.63 | -7,438.51 | -6,598.68 | -7,438.51 |
| EPS Diluted Continuous Ops | -1,606.35 | -6,852.55 | -7,416.55 | -6,476.68 | -7,451.86 |
| EBITDA(a) | $8,296 | $-28,229 | $-33,277 | $-37,103 | $-28,743 |